Pharmafile Logo

transcreation

- PMLiVE

NHS England launches lung cancer awareness drive in country’s cancer hotspots

Only 57% of those surveyed recognised a persistent cough as a symptom of lung cancer

- PMLiVE

InflaRx seeks FDA authorisation for vilobelimab for critically ill COVID-19 patients

A phase 3 study showed that the antibody reduced the all-cause mortality rate after 28 days

- PMLiVE

Medscape presents Digital Health in Practice: Impact & Insights at Reuters #Pharma2020

Medscape will be attending the Reuters Events Pharma 2022 conference from 11 – 13 October at Nice Acropolis Convention Center in Nice, France. The Medscape Professional Network will connect with...

Medscape Education

Overcoming Patient Recruitment Challenges in Rare Disease Trials

Rare diseases are thought to affect up to 446 million people worldwide. With more than 7,000 rare diseases, most of which are genetic, it’s vital all patients can access new...

Innovative Trials

- PMLiVE

A powerful care platform connects medical professionals and patients

Education platforms that disseminate the latest advances in cardiovascular medicine to cardiologists, physicians and healthcare professionals are helping deliver better outcomes for heart patients.

Medscape Education

- PMLiVE

Amylyx’s Relyvrio receives FDA approval for ALS treatment

Relyvrio was shown to significantly slow physical decline in people living with ALS

- PMLiVE

Cancer Research UK scientists announce ‘breakthrough’ in understanding of metastasis

The team found that cancer cells ‘exploit’ the body’s tissue repair process to spread cells

- PMLiVE

Sanofi and Regeneron’s Dupixent approved by FDA for prurigo nodularis

The two phase 3 trials showed a meaningful reduction in itching

Modern Medical Affairs: How to Leverage Tech and Data as an MSL

Dr. Luca Dezzani, VP of US Oncology Medical Affairs at Johnson & Johnson, explores innovation in Medical Affairs, new technologies for data dissemination and medical education, how to engage with...

Impetus Digital

- PMLiVE

The Creative Engagement Group appoints Tom Griffiths from Saatchi & Saatchi Wellness as Strategy and Planning Director

The Creative Engagement Group has appointed experienced healthcare and digital strategist Tom Griffiths.

The Creative Engagement Group

Is communication failing us?

Compelling people to care in a world oversaturated with news and information

Page & Page Health

- PMLiVE

Are your field teams ready to excel in the new era?

A qualitative research approach to help you critically assess post-pandemic learnings and ignite the potential of meaningful interactions with HCPs.

The Creative Engagement Group

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links